REVIVA PHARMACEUTICALS HOLDINGS, INC.

Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.

RVPH | US

Overview

Corporate Details

ISIN(s):: VGG8708A1167 (+1 more)
LEI:
Country:: United States of America
Address:: 10080 N WOLFE ROAD, 95014 CUPERTINO
Website:: https://revivapharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for diseases with significant unmet medical needs. The company utilizes a chemical genomics-driven technology platform to develop treatments with improved safety and efficacy profiles. Its primary areas of focus include central nervous system (CNS), respiratory, and metabolic diseases. The company's lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, and psychosis associated with Alzheimer's and Parkinson's diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REVIVA PHARMACEUTICALS HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REVIVA PHARMACEUTICALS HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REVIVA PHARMACEUTICALS HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
EyePoint Pharmaceuticals, Inc. Develops innovative, sustained-delivery therapeutics for retinal diseases.	United States of America	EYPT
Faes Farma S.A. Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.	Spain	FAE
Fagron N.V. Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.	Belgium	FAGR
Farmak A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.	Ukraine	FARM
Farmsintez ao Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.	Russian Federation	LIFE
FATE THERAPEUTICS INC Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.	United States of America	FATE
FENNEC PHARMACEUTICALS INC. Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.	United States of America	FENC
FibroBiologics, Inc. Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.	United States of America	FBLG
FIBROGEN INC Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.	United States of America	FGEN
Fine Foods & Pharmaceuticals Ntm Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.	Italy	FF